Biobanks
Biobanks, also known as biorepositories, are a reservoir for human biological samples obtained from patients or living donors. Dedicated organisations with sophisticated infrastructure and facilities gather, process, store, and supply human biomaterials to the biomedical research organisations.
Biorepositories banks the remnant samples collected from clinical laboratories after diagnosis or samples directly collected from patients or human donors during clinical trials or routine laboratory examinations. Researchers can gain access to data of millions of donors through biobanks, reflecting a huge part of the population.
Biobanking of human samples or human biological specimens for research are done with utmost care and permanent quality checks and testing. Modern biobanks concentrate on collecting and storing specimens with comprehensive clinical, demographic and biological information. Besides, biobanks research is also keen to ensure strict adherence to the stringent IRB protocol, SOPs, and ICH-GCP guidelines while handling and preserving human biospecimens for the future. This helps in practicing strict quality control to maintain higher standards in retaining the sample’s physiological integrity to meet the best research outcome.
Human biobanks open human biodiversity mechanisms
In this era of new human biology, translational, diagnostic and biomedical research is gaining more attention, such as human biospecimens. Uprooting the concept of "one-size-that-fits-all" in medical practice, today's patient-centric approach of individualized therapy has become the patient's fundamental right. Soon, we can expect a remarkable transformation from contemporary medical practice to a more evidence-based precision medicine approach. It is an advanced disease management concept to prevent and treat diseases by developing a therapeutic plan tailored to an individual. Inter-individual variation in the genetic makeup, lifestyle, environmental exposures is the major guiding factors to customised treatment.
Furthermore, human specimens or patient samples are essential for precision medicine research as they are a vital formation source of a patient’s clinical condition, illness, and biological origin. To be precise, Human biospecimen studies can unlock the complex mechanism of human biodiversity. It clarifies and elucidates the underlying pathological and physiological mechanism responsible for the difference in human health conditions. Also, it helps to study deeper the root cause for the inter-individual difference in response to disease and the treatment. Therefore, human biosamples or biological specimens can be an inevitable component of contemporary precision medicine research. Since they can provide previously unknown real-world evidence of disease biology, progression and response of different individuals to therapy. Therefore, human biobank research is the key to personalized medicine. Another critical area where human biosamples can contribute is population-based studies. Biospecimens stored at population biobanks help to accelerate the discovery of more effective indigenous therapeutic agents, algorithms, or vaccinations to best tackle the endemic disease.
Commercial biobanks are the largest biospecimen provider
According to several estimates, from 2018, the market size of human biobanking is constantly increasing and is expected to follow the current trend in the following years. Commercial biobanks are the major contributor to boosting biobanking market growth among all biobanks. As we know, biobanking is a complex procedure requiring substantial financial investment; commercial biobanks have boomed up in recent years. Paradoxically, public biobanks are running a slow race. Building up storage facilities like freezers and cryogenic units and practicing active quality control are some of the crucial areas requiring high-budget planning. Besides, securing reliable funding or financial aid from the responsible government bodies is another major roadblock before public biobanks. Therefore, in recent years the biobanking sector has experienced a significant shift from the public environment to the commercial one.
Consequently, commercial biobanks have grown both in number and size in a short period, becoming the largest human biospecimen provider in the world market. Besides, the sudden outbreak of the COVID-19 pandemic and urgent demand for research specimens on a large scale directly boosted the possibilities of human biobanks. Therefore, in the future commercial biobanks will become one of the lucrative industries among all the healthcare sectors.
Central BioHub connects biobanks to researchers
Well annotated, high-quality human biospecimens are paramount for precision medicine research. Moreover, the availability of research samples at the right time in the correct quantity is essential for keeping the study progressive for a moon-shot discovery. Central BioHub is one of the leading human biospecimen marketplace connecting biobanks to researchers across the globe. We partner with numerous certified biorepositories located in different parts of the world. Bringing millions of authentic human biospecimens together in a unique digital platform, Central BioHub facilitates the researchers' easy procurement of research specimens.
Embracing innovative digital data-driven technology, Central BioHub presents a next-generation digital platform to make banked samples readily available for purchase. Moreover, our fastest global transportation network delivers the ordered research samples to your location. Prioritizing customer satisfaction of the researchers, Central BioHub allows easy procurement of research samples with complete assistance from our scientific experts. Don't wait - quickly navigate through our inventory and experience the simplicity of biospecimen procurement at your fingertips. Also, explore advanced search options to clinical research specimens from Central BioHub, by clicking clinical diagnosis, ICD-10-CM codes, and laboratory parameters.